Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001237648-20-000057)

Filing Details

Accession Number:: 0001237648-20-000057
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-09 15:35:36
Reporting Period:: 2020-10-08

Accepted Time:: 2020-10-09 15:35:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1038133	Heska Corp	HSKA	In Vitro & In Vivo Diagnostic Substances (2835)	770192527

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1570492	S. Kevin Wilson	3760 Rocky Mountain Avenue Loveland CO 80538	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-10-08	700	$109.00	3,488	No	4	S	Indirect	by Daughter
Common Stock	Disposition	2020-10-08	1,000	$109.00	3,086	No	4	S	Indirect	by Son
Common Stock	Disposition	2020-10-08	683	$109.00	3,505	No	4	S	Indirect	by Son II
Common Stock	Disposition	2020-10-08	746	$109.00	3,342	No	4	S	Indirect	by Son III

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	by Daughter
No	4	S	Indirect	by Son
No	4	S	Indirect	by Son II
No	4	S	Indirect	by Son III

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	72,955	Direct
Common Stock	162,763	Indirect	by Cuattro, LLC
Common Stock	7,000	Indirect	by Spouse
Common Stock	138,743	Indirect	by Wilson Family Tr.

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 6, 2020.